San Diego, CA · Founded 2017 · Privately Held (backing)
Developer of an orally administered toll-like receptor agonist designed to stimulate innate immunity in cancer immunotherapy. Primmune Therapeutics is based in San Diego, CA and was founded in 2017. It was valued at $44 million at its early-stage round in Jan 2021, the last priced event on record. It has raised $63.2 million across 5 recorded rounds; the latest was a $13 million early-stage round in Oct 2020.
These 9 firms already write checks for companies like Primmune Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.